Expandable device delivery

Information

  • Patent Grant
  • 9149277
  • Patent Number
    9,149,277
  • Date Filed
    Monday, October 18, 2010
    13 years ago
  • Date Issued
    Tuesday, October 6, 2015
    8 years ago
Abstract
A device for delivering an expandable member to a luminal structure in a patient is described. In some embodiments, the device has a carrier member, with a carrier lumen extending at least partially therethrough. The device can have an elongate member that extends through the carrier lumen across a first notch in the carrier member. The device can have an expandable member that expands within and engages the luminal structure, can be carried by the carrier member, and has a first portion that fits within the first notch. When the elongate member extends through the carrier lumen and across the first notch, the elongate member secures the first portion to the carrier member. The elongate member is configured to move axially through the carrier lumen such that the elongate member permits release of the first portion from the carrier member and expansion of at least part of the expandable member.
Description
FIELD

The present invention generally relates to methods and devices for delivering an expandable member to a luminal structure in a patient.


BACKGROUND

Devices exist for stenting luminal structures in patients. Stents typically maintain patency in luminal structures such as blood vessels. As a result, flow of fluid such as blood through the luminal structures is generally maintained.


SUMMARY

Problems associated with typical devices for occluding flow through luminal structures of patients include inaccurate positioning and engagement of these devices within the luminal structures, as well as having continuous and significant residual flow. These devices, once placed, do not provide mechanisms allowing for their repositioning and/or removal in a simple manner. Thus, once these devices have been placed, the devices are typically committed to their initially placed positions. It is therefore desirable to provide devices that can be used to reduce or stop flow through a luminal structure in a patient, and also allow for their repositioning and/or removal.


According to various embodiments of the subject technology, a device is provided for delivering an expandable member to a luminal structure in a patient. The device comprises a carrier member, positionable in a luminal structure in a patient and having a cross-sectional area. The cross-sectional area comprises a first half and a second half that are separated by a line segment. The line segment intersects a point along a central long axis of the carrier member. The carrier member further has a carrier lumen extending axially at least partially through the carrier member and intersecting solely the first half of the cross-sectional area. The device also comprises a first notch in the carrier member, wherein, when the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the first notch. The device comprises an elongate member that extends through the carrier lumen across the first notch, and an expandable member configured to expand within and engage the luminal structure and to be carried by the carrier member, and having a first portion that fits within the first notch. When the elongate member extends through the carrier lumen and across the first notch, the elongate member secures the first portion to the carrier member. When the first portion is secured to the carrier member, the first portion intersects solely the first half. The elongate member is configured to move axially through the carrier lumen such that the elongate member permits release of the first portion from the carrier member and expansion of at least part of the expandable member.


In some embodiments, the elongate member is configured to be retracted by an operator such that the elongate member permits the release of the first portion. In some embodiments, the elongate member permits the release of the first portion when the elongate member does not fully extend across the first notch. In some embodiments, the elongate member comprises a wire. In some embodiments, when expanded within and engaging the luminal structure, the expandable member substantially reduces flow of the body fluid through the luminal structure. In some embodiments, the expandable member fully obstructs flow of the body fluid through the luminal structure. In some embodiments, the expandable member is helically arranged about the carrier member. In some embodiments, the expandable member is coiled around the carrier member before being released from the carrier member.


In some embodiments, the device further comprises a catheter through which the carrier member moves when positioned within the luminal structure. In some embodiments, when the elongate member secures the first portion to the carrier member, the elongate member lies exterior to the first portion relative to the central long axis of the carrier member.


According to certain embodiments, the device further comprises a second notch in the carrier member. When the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the second notch. The elongate member extends through the carrier lumen across the second notch. The expandable member comprises a second portion that fits within the second notch. When the elongate member extends through the carrier lumen and across the second notch, the elongate member secures the second portion to the carrier member. When the second portion is secured to the carrier member, the second portion intersects solely the first half. The elongate member is configured to move axially through the carrier lumen, after the first portion is released from the carrier member, such that the elongate member permits release of the second portion from the carrier member and release of the expandable member from the carrier member. In some embodiments, when the elongate member secures at least one of the first portion and the second portion to the carrier member, the elongate member lies exterior to at least one of the first portion and the second portion relative to the central long axis of the carrier member.


According to various embodiments of the subject technology, a method for delivering an expandable member to a luminal structure in a patient is provided. The method comprises positioning a carrier member in a luminal structure in a patient. The carrier member has a cross-sectional area comprising a first half and a second half that are separated by a line segment intersecting a point along a central long axis of the carrier member. The carrier member further has a carrier lumen extending at least partially through the carrier member and intersecting solely the first half. The carrier member has a first notch. When the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the first notch. An elongate member extends through the carrier lumen across the first notch. An expandable member is carried by the carrier member and includes a first portion that fits within the first notch. The expandable member is configured to expand within and engage the luminal structure. When the elongate member extends through the carrier lumen and across the first notch, the elongate member secures the first portion to the carrier member. When the first portion is secured to the carrier member, the first portion intersects solely the first half. The method also comprises moving the elongate member axially through the carrier lumen such that the elongate member permits release of the first portion from the carrier member and expansion of at least part of the expandable member.


In some embodiments, the moving comprises retracting the elongate member by an operator who is performing the retracting. In some embodiments, the elongate member permits the release of the first portion when the elongate member does not fully extend across the first notch. In some embodiments, the expandable member is helically arranged about the carrier member. In some embodiments, the expandable member is coiled around the carrier member before being released from the carrier member. In some embodiments, when the elongate member secures the first portion to the carrier member, the elongate member lies exterior to the first portion relative to the central long axis of the carrier member. In some embodiments, the elongate member comprises a wire.


According to certain embodiments, the method further comprises moving the carrier member through a catheter when positioning the carrier member within the luminal structure.


According to certain embodiments, the method further comprises substantially reducing, with the expandable member, flow of the body fluid through the luminal structure when the expandable member is expanded within and engaging the luminal structure. In some embodiments, the method further comprises fully obstructing, with the expandable member, flow of the body fluid through the luminal structure when the expandable member is expanded within and engaging the luminal structure.


According to certain embodiments, the carrier member further comprises a second notch. When the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the second notch. The elongate member extends through the carrier lumen across the second notch. The expandable member comprises a second portion that fits within the second notch. When the elongate member extends through the carrier lumen and across the second notch, the elongate member secures the second portion to the carrier member. When the second portion is secured to the carrier member, the second portion intersects solely the first half The method further comprises moving, after the first portion is released from the carrier member, the elongate member axially through the carrier lumen such that the elongate member permits release of the second portion from the carrier member and release of the expandable member from the carrier member. In some embodiments, when the elongate member secures at least one of the first portion and the second portion to the carrier member, the elongate member lies exterior to at least one of the first portion and the second portion relative to the central long axis of the carrier member.


According to various embodiments of the subject technology, a device for delivering an expandable member to a luminal structure in a patient is provided. The device comprises a carrier member, positionable in a luminal structure in a patient and having a carrier lumen extending axially at least partially through the carrier member. The carrier lumen is bounded by a boundary having a boundary cross-sectional shape. The device also comprises a first notch in the carrier member, wherein, when the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the first notch. The boundary has a first discontinuity at the first notch, between a first boundary end and a second boundary end. The device comprises an elongate member that extends through the carrier lumen and across the first notch. A first projection, having a cross-sectional shape that is substantially the same as the boundary cross-sectional shape, extends from the first boundary end, across the first discontinuity, to the second boundary end. The device comprises an expandable member configured to expand within and engage the luminal structure and to be carried by the carrier member, and having a first portion comprising a first free end. The first portion fits within the first notch. In some embodiments, when the elongate member extends through the carrier lumen and across the first notch, and when the elongate member secures the first portion to the carrier member, the first free end lies outside the first projection and/or the boundary. In some embodiments, the elongate member is configured to move axially through the carrier lumen such that the elongate member permits release of the first portion from the carrier member and expansion of at least part of the expandable member.


In some embodiments, the carrier member has a cross-sectional area comprising a first half and a second half that are separated by a line segment intersecting a point along a long axis of the carrier member. In some embodiments, the carrier lumen intersects solely the first half. In some embodiments, when the first portion is secured to the carrier member, the first portion intersects solely the first half.


According to certain embodiments, the device further comprises a second notch in the carrier member. When the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the second notch. The boundary has a second discontinuity at the second notch, between a third boundary end and a fourth boundary end. The elongate member extends through the carrier lumen and across the second notch. A second projection, having a cross-sectional shape that is substantially the same as the boundary cross-sectional shape, extends from the third boundary end, across the second discontinuity, to the fourth boundary end. The expandable member comprises a second portion comprising a second free end, the second portion fitting within the second notch. In some embodiments, when the elongate member extends through the carrier lumen and across the second notch, and when the elongate member secures the second portion to the carrier member, the second free end lies outside the second projection and/or the boundary. In some embodiments, the elongate member is configured to move axially through the carrier lumen, after the first portion is released from the carrier member, such that the elongate member permits release of the second portion from the carrier member and release of the expandable member from the carrier member.


In some embodiments, when the second portion is secured to the carrier member, the second portion intersects solely the first half. In some embodiments, when the elongate member secures at least one of the first portion and the second portion to the carrier member, the elongate member lies exterior to at least one of the first portion and the second portion relative to the central long axis of the carrier member. In some embodiments, the first projection is collinear with the boundary.


According to certain embodiments, the elongate member is configured to be retracted by an operator such that the elongate member permits the release of the first portion. The elongate member permits the release of the first portion when the elongate member does not fully extend across the first notch. In some embodiments, the elongate member comprises a wire. When expanded within and engaging the luminal structure, the expandable member substantially reduces flow of the body fluid through the luminal structure. In some embodiments, the expandable member fully obstructs flow of the body fluid through the luminal structure.


According to certain embodiments, the expandable member is helically arranged about the carrier member. The expandable member is coiled around the carrier member before being released from the carrier member. In some embodiments, the device further comprises a catheter through which the carrier member moves when being positioned within the luminal structure. In some embodiments, when the elongate member secures the first portion to the carrier member, the elongate member lies exterior to the first portion relative to a central long axis of the carrier member.


Additional features and advantages of the invention will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the invention. The advantages of the invention will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.


It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are included to provide further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate aspects of the invention and together with the description serve to explain the principles of the invention.



FIG. 1 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, in accordance with various embodiments of the subject technology.



FIG. 2 illustrates a detailed view of the example of FIG. 1, in accordance with various embodiments of the subject technology.



FIG. 3A illustrates a cross sectional view of the example of FIGS. 1 and 2, taken along line 3-3 of FIG. 2, and having a first portion of an expandable member fitting in a first notch of a carrier member and an elongate member extending across the first notch, in accordance with various embodiments of the subject technology.



FIG. 3B illustrates a perspective view of an example of a first portion of an expandable member fitting in a first notch of a carrier member, in accordance with various embodiments of the subject technology.



FIG. 4 illustrates a detailed view of the example of FIGS. 1-3A, showing the first portion of the expandable member in the first notch, in accordance with various embodiments of the subject technology.



FIG. 5 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, having a catheter and a first portion of an expandable member fitting in a first notch of a carrier member and an elongate member extending across the first notch, in accordance with various embodiments of the subject technology.



FIG. 6 illustrates a catheter with a core and guide wire in a luminal structure of a patient, in accordance with various embodiments of the subject technology.



FIG. 7 illustrates the catheter of FIG. 6, with the core and guide wire removed, in accordance with various embodiments of the subject technology.



FIG. 8 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, having a carrier member, with an expandable member fitting in a first notch and a second notch of the carrier member, and having an occlusion membrane positioned thereabout, in accordance with various embodiments of the subject technology.



FIG. 9 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, having a carrier member, with an expandable member fitting in a first notch and a second notch of the carrier member, and having an occlusion membrane positioned thereabout, positioned in the luminal structure, and extending from a catheter, in accordance with various embodiments of the subject technology.



FIG. 10 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, positioned in the luminal structure, and extending from a catheter in the luminal structure, in accordance with various embodiments of the subject technology.



FIG. 11 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, expanded in the luminal structure, in accordance with various embodiments of the subject technology.



FIG. 12 illustrates an example of a device for reducing or stopping flow through a luminal structure in a patient, expanded within and engaging the luminal structure, with a carrier member removed, in accordance with various embodiments of the subject technology.



FIG. 13 illustrates an example of a carrier member having slots, in accordance with various embodiments of the subject technology.



FIG. 14 illustrates an example of a carrier member having a tapered cut, in accordance with various embodiments of the subject technology.



FIG. 15 illustrates an example of a device having an expandable member covered by an occlusion membrane, in accordance with various embodiments of the subject technology.



FIG. 16 illustrates an example of a device having an expandable member covered by an occlusion membrane, in accordance with various embodiments of the subject technology.



FIG. 17 illustrates an example of a method for reducing or stopping flow through a luminal structure in a patient, in accordance with various embodiments of the subject technology.





DETAILED DESCRIPTION

In the following detailed description, numerous specific details are set forth to provide a full understanding of the present invention. It will be apparent, however, to one ordinarily skilled in the art that the present invention may be practiced without some of these specific details. In other instances, well-known structures and techniques have not been shown in detail so as not to obscure the present invention.



FIGS. 1-4 illustrate an example of device 10 for delivering expandable member 12 to luminal structure 14 (illustrated in FIGS. 9-12) in a patient to reduce or stop flow through luminal structure 14, in accordance with various embodiments of the subject technology. Device 10 comprises carrier member 16, positionable in luminal structure 14 in the patient. Referring to FIGS. 3A and 3B, carrier member 16 has cross-sectional area 18 comprising first half 20 and second half 22 that are separated by line segment 24 intersecting point 26 along a central long axis of carrier member 16. In some embodiments, carrier member 16 has carrier lumen 28 extending at least partially through carrier member 16 and intersecting solely first half 20. Carrier member 16 has first notch 30, wherein, when carrier member 16 is positioned in luminal structure 14, carrier lumen 28 is in fluid communication with a body fluid in luminal structure 14 at first notch 30. First notch 30 may be a notch or ring placed distally at a tip (e.g., about 1-2 mm from the end) of a distal edge of carrier member 16. Carrier member 16 may be nylon, stainless steel hypotube, or any other suitable material. According to certain embodiments, a proximal end of carrier member 16 is made of nylon with changeable durometer or stainless steel (optionally slotted for flexibility) hypotube, and a distal end of carrier member 16 is made of stainless steel hypotube, about 0.20-0.40″ OD (0.5-1 mm). In some embodiments, carrier member 16 may have a solid cross-sectional area except where carrier lumen 28 extends and/or except where a notch (e.g., first notch 30) is formed on carrier member 16. For example, wall 31 of carrier member 16 may form an inner wall of first notch 30, and may be have a solid cross-sectional area covering at least second half 22. In some embodiments, wall 31 may have a smaller solid cross-sectional area provided that wall 31 forms the inner wall of first notch 30 (e.g., like a table separating a table top area from a table bottom area).


Device 10 also comprises elongate member 32 that extends through carrier lumen 28 across first notch 30 and expandable member 12 configured to expand within and engage luminal structure 14. Expandable member 12 is configured to be carried by carrier member 16 and has first portion 34 that fits within first notch 30. Elongate member 32 extends through carrier lumen 28 and across first notch 30, securing first portion 34 of expandable member 12 to carrier member 16. Elongate member 32 lies exterior to first portion 34, relative to the central long axis of carrier member 16 and may be micro welded in place. Elongate member 32 is configured to be retracted by an operator, permitting the release of first portion 34. When elongate member 32 does not fully extend across first notch 30, elongate member 32 permits the release of first portion 34. Elongate member 32 is illustrated as a tungsten wire. However, other elongated structures, such as ribbon, cable, small diameter hypotube, or other elongated materials may be used. In some embodiments, a cross-sectional diameter of carrier member 16 may be between 0.018 inches and 0.068 inches. In some embodiments, a combined cross-sectional diameter of carrier member 16 and elongate member 32 when elongate member 32 is carried by carrier member 16 may be between 0.018 inches and 0.068 inches.


In some embodiments, carrier lumen 28 is bounded by boundary 27 having a boundary cross-sectional shape, in accordance with various embodiments of the subject technology. The boundary cross-sectional shape may be at least one of an elliptical, rectangular, and polygonal shape. Boundary 27 has a first discontinuity at first notch 30, between first boundary end 27a and second boundary end 27b. In some embodiments, first projection 29, having a cross-sectional shape that is substantially the same as the boundary cross-sectional shape, extends from first boundary end 27a, across the first discontinuity, to second boundary end 27b. In some embodiments, elongate member 32 extends through first projection 29. In some embodiments, elongate member 32 has a cross-sectional shape that is substantially the same as the boundary cross-sectional shape. In some embodiments, elongate member 32 has a cross-sectional area that is less than a cross-sectional area of the boundary cross-sectional shape. In some embodiments, first projection 29 is collinear with boundary 27. First portion 34 comprises free end 35. In some embodiments, when elongate member 32 extends through carrier lumen 28 and across first notch 30, and when elongate member 32 secures first portion 34 to carrier member 16, first free end 35 lies outside first projection 29 and/or boundary 27. In some embodiments, “projection,” as used herein, refers to a shape defining boundaries that has no physical manifestation. For example, first projection 29 may be a virtual cylinder and is not an actual physical structure. In some embodiments, “projection,” as used herein, is given its plain ordinary meaning.


According to certain embodiments, carrier member 16 may further comprise second notch 36 wherein, when carrier member 16 is positioned in luminal structure 14, carrier lumen 28 is in fluid communication with a body fluid in luminal structure 14 at second notch 36. Elongate member 32 may extend through carrier lumen 28 across second notch 36 and expandable member 12 may have second portion 38 that fits within second notch 36. Elongate member 32 extends through carrier lumen 28 and across second notch 36, securing second portion 38 of expandable member 12 to carrier member 16. Elongate member 32 lies exterior to second portion 38, relative to the central long axis of carrier member 16 and may be micro welded in place. When second portion 38 of expandable member 12 is secured to carrier member 16, second portion 38 intersects solely first half 20. Elongate member 32 is configured to move axially through carrier lumen 28 after first portion 34 of expandable member 12 is released from carrier member 16, such that elongate member 32 permits release of second portion 38 from carrier member 16. Such release may be a final or complete release of expandable member 12 from carrier member 16. As illustrated in FIG. 1, a single elongate member 32 secures first portion 34 and second portion 38 of expandable member 12 to carrier member 16 at respective first notch 30 and second notch 36. Alternatively, separate elongate members may be used for each instance where a notch is provided in carrier member 16 for engagement with expandable member 12. For example, a first elongate member may be used with first notch 30 to secure first portion 34 of expandable member 12 to carrier member 16, while a second elongate member is used with second notch 36 to secure second portion 38 of expandable member to carrier member 16. In such an embodiment, the first and second elongate members may act completely independently, such that the first elongate member releases the first portion 34 and the second releases the second portion 38. Such a configuration may allow complete independence of distal release from proximal and vice versa. In some such embodiments, the first elongate member may be of uniform cross-section, while the second elongate member may be tapered from proximal to distal, and may serve as an internal kink-resistant support.


Device 10 may also comprise occlusion membrane 40 or other flow reducing member coupled to expandable member 12 such that when expandable member 12 is expanded within and engaging luminal structure 14, expandable member 12 substantially reduces flow of body fluid through luminal structure 14. When expandable member 12 is positioned within the lumen, occlusion membrane 40 may substantially reduce or fully obstruct flow of at least one of emboli and fluid flowing through the lumen. Occlusion membrane 40 may be secured and placed inside and/or outside of expandable member 12. In some aspects, occlusion membrane 40 may be coupled to expandable member 12 using surgical suture.


In some embodiments, expandable member 12 is arranged in a spiral or other helical configuration about carrier member 16. Expandable member 12 may be beneficially expanded in a radial direction to engage an inner surface of the lumen. Should the inner surface of the lumen apply a radially compressive force on any portion of expandable member 12, the spiral configuration of expandable member 12 allows for such a force to be dispersed along the entirety of expandable member 12, thereby providing strong structural support for expandable member 12 to be placed within the lumen. In some embodiments, the spiral configuration allows for expandable member 12 to withstand long-term pulsatile loads of torque and bending, and beneficially reduces risks of fatigue breaks, cracks, etc. In some embodiments, expandable member 12 may be arranged to have more or less coils in the spiral configuration depending on a desired size a desired placement, and a desired compressibility of expandable member 12, and other suitable factors known to those of ordinary skill in the art. In some embodiments, expandable member 12 is highly flexible while providing sufficient rigidity to be guided through the lumen. In some embodiments, tapered distal portion 42 comprises one to two coils of expandable member 12.


Although expandable member 12 is arranged in the spiral configuration, other suitable configurations known to those of ordinary skill in the art may be used. In some embodiments, expandable member 12 comprises one or more anchors configured to engage an inner surface of the lumen for resisting axial movement of expandable member 12 when expandable member 12 is deployed within the lumen. For example, the one or more anchors may be protrusions, or hair-like wires of the same material as expandable member 12.


According to certain embodiments, device 10 may be removed from within the lumen by inverting expandable member 12. For example, an axial force in the proximal direction may be applied to distal portion 42 such that distal portion 42 moves within and toward second portion 38. In some embodiments, such an inversion causes expandable member 12 to “unwind” from its spiral configuration, in which case the axial force may continue to be applied until expandable member 12 disengages from the inner surface of the lumen. In some embodiments, expandable member 12 may maintain its spiral configuration after the inversion, but otherwise have a reduced cross sectional dimension as an inverted expandable member 12. In such a case, the inverted expandable member 12 may be easily removed from within the lumen because of the reduced cross sectional dimension.


According to various embodiments of the subject technology, expandable member 12 may comprise at least one of stainless steel, nickel titanium (NiTi), cobalt chromium (CoCr), titanium, a polymer, a polyester based material, a tyrosine based polycarbonate, a polyethylene based material, Teflon (e.g., including expanded Teflon), and other suitable materials known to those of ordinary skill in the art. In some embodiments, expandable member 12 may comprise at least one of polyethylene, polyglicolide, polylactide, ε-caprolactone, polycarbonate, hydroxyalkanote, para dioxinine, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), PLA, PGA, PLLA, PDLLA, PDO, PCL, and other suitable materials known to those of ordinary skill in the art. In some embodiments, expandable member 12 and/or occlusion membrane 40, may comprise a bioabsorbable material, beneficially allowing for their controlled degradation. In some embodiments, expandable member 12 and/or occlusion membrane 40 may be formed of bioabsorbable material to have a controlled degradation anywhere between about 3 months to about 3 years depending on the desired application of device 10. In some embodiments, the controlled degradation may be less than about 3 months or greater than about 3 years. For example, hydrolysis of ester linkages or effects of enzymatic degradation may be utilized for the controlled degradation.


In some embodiments, expandable member 12 may be coated with various suitable agents to allow expandable member 12 to expand within and engage the inner surface of the lumen. For example, expandable member 12 may be coated with biological glue. In some embodiments, the biological glue may comprise glue from at least one of crab shells, spider webs, gecko feet, burrowing frogs, mussels, and caulobacter crescentus bacteria. In some embodiments, expandable member 12 may be coated with a friction-resistant coating (e.g., a friction-resistant polymer coating). In some embodiments, radio-opaque markers may be located on carrier member 16, expandable member 12, occlusion membrane 40, elongate member 32 and/or catheter 44 for endovascular or other image-guided procedures. For example, a radio-opaque marker may be placed on a first coil of expandable member 12. In some embodiments, an outer cross sectional dimension of the first coil is less than an outer cross sectional dimension of a second coil of expandable member 12, which will allow space for the radio-opaque marker to surround, at least in part, an exterior of the first coil. In some embodiments, the first coil is adjacent to the second coil, and occlusion membrane 40 may be coupled to the second coil. In this regard, having the radio-opaque marker placed on the first coil adjacent to the second coil that is coupled to occlusion membrane 40 will allow an operator of device 10 to identify where embolization may occur, for example. In some embodiments, the radio-opaque marker may be a platinum iridium alloy or other suitable markers known to those of ordinary skill in the art.


According to various embodiments of the subject technology, occlusion membrane 40 may be used to occlude, partially or completely, luminal structure 14 in which device 10 is deployed. In some embodiments as used herein, occlusion may refer to either partial or complete occlusion. In some embodiments, occlusion membrane 40 comprises at least one of a polyurethane, a polyanhidrate, PTFE, ePTFE, and other suitable materials known to those of ordinary skill in the art. In some embodiments, occlusion membrane 40 may be elastic. In some embodiments, occlusion membrane 40 may be permeable or non-permeable.


According to certain embodiments, occlusion membrane 40 forms a continuous cover without a flap. For example, occlusion membrane 40 may form a cover at distal portion 42. In some embodiments, occlusion membrane 40 may comprise a plurality of pores each having a diameter of between about 5 microns and about 10 microns, which may be beneficial for occluding blood, for example. In some embodiments, occlusion membrane 40 may comprise a plurality of pores each having a diameter less than about 5 microns or greater than about 10 microns. In some embodiments, occlusion membrane 40 may comprise a plurality of pores each having a diameter less than about 3 microns. In some embodiments, occlusion membrane 40 may comprise a plurality of pores each having a diameter less than about 1 micron. In some embodiments, occlusion membrane 40 may comprise a plurality of pores each having a diameter greater than about 13 microns. In some embodiments, occlusion membrane 40 may comprise a plurality of pores each having a diameter greater than about 16 microns. Although occlusion membrane 40 is shown as disposed at distal portion 42, occlusion membrane 40 may be disposed over other portions of expandable member 12 depending on the desired placement of occlusion membrane 40, desired application of device 10, etc. For example, occlusion membrane 40 may be disposed over a proximal portion or middle portion of expandable member 12. In another example, occlusion membrane 40 may be disposed over the proximal portion, middle portion, and distal portion 42.


In some embodiments, a length of expandable member 12 may be between about 7 millimeters (mm) and about 9 mm. In some embodiments, the length of expandable member 12 may be less than about 7 mm or greater than about 9 mm. According to certain embodiments, a combined length of the proximal portion and the middle portion may be between about 4 mm and about 5 mm to provide adequate anchoring of expandable member 12 with respect to distal portion 42 (e.g., between about 40% and about 70% of the length of expandable member 12). In some embodiments, the combined length of the proximal portion and the middle portion may be less than about 4 mm or greater than about 5 mm. In some embodiments, a length of distal portion 42 may be between about 3 mm and about 4 mm. In some embodiments, the length of distal portion may be less than about 3 mm or greater than about 4 mm. In some embodiments, a diameter of the proximal portion and/or the middle portion may be between about 2 mm and about 10 mm. In some embodiments, the diameter of the proximal portion and/or the middle portion may be less than about 2 mm or greater than about 10 mm. In some embodiments, a diameter of distal portion 42 may be between about 0.4 mm and about 0.5 mm. In some embodiments, the diameter of distal portion 42 may be less than about 0.4 mm or greater than about 0.5 mm.


In some embodiments, an average thickness of occlusion membrane 40 is between about 0.0005 inches and about 0.006 inches. In some aspects, the average thickness of occlusion membrane 40 may be less than about 0.0005 inches or greater than about 0.006 inches. In certain embodiments, an average thickness of a distal portion of occlusion membrane 40 is greater than an average thickness of a proximal portion of occlusion membrane 40. Such a configuration may ensure that more flow may be reduced at the distal portion of occlusion membrane 40. In some embodiments, the average thickness of the distal portion of occlusion membrane 40 is between about 0.002 inches and about 0.012 inches. In some embodiments, the average thickness of the distal portion of occlusion membrane 40 may be less than about 0.002 inches or greater than about 0.012 inches. In some embodiments, the average thickness of the proximal portion of occlusion membrane 40 is between about 0.0005 inches and about 0.006 inches. In some embodiments, the average thickness of the proximal portion of occlusion membrane 40 may be less than about 0.0005 inches or greater than about 0.006 inches.


According to various aspects of the subject technology, device 10 may be used for various applications for reducing or stopping flow through a luminal structure in a patient. Device 10 may be used for rapid, well-controlled, and reliable occlusion of luminal structures. For example, the luminal structure may comprise at least one of a blood vessel, a body organ, a lung, an airway, a Fallopian tube, a cervical canal, a vagina, a cervix, a vas deferens, a bronchus, a ureter, a colon, a rectum, an anus, a bio duct, a pancreatic duct, or other suitable tubular structures known to those of ordinary skill in the art. In some embodiments, device 10 may be used for temporary occlusion in cases of lung disease, or for temporary occlusion of female reproductive organs for contraceptive purposes. In some embodiments, device 10 may be removed, or flow may be restored through the luminal structure to restore original organ functions.


In some embodiments, device 10 may be used for various endoluminal occlusion procedures, including procedures for the lungs (e.g., selective endobronchial occlusion for lung reduction, occlusion of bronchopleural or bronchocutaneous fistulas, endovascular occlusion of pulmonary AVMs and fistulas or aortopulmonary anastomoses) and procedures for reproductive organs (e.g., endoluminal occlusion of vas deferens or Fallopian tubes for minimally-invasive contraceptive intervention, endovascular occlusion of varicocele in males and low abdominal gonadal veins for reducing or completely eliminating chronic pelvic pain syndrome in females). In some embodiments, device 10 may be used for stopping blood loss from a damaged blood vessel, closing an abnormal blood vessel or a blood vessel supplying a vascular anamaly, or interrupting blood supply to an organ or part of an organ for permanent devascularization (e.g., closure of splenic artery in spleen laceration, devascularization of tissues involved by neoplastic process, either pre-operatively or as a palliative measure). In some embodiments, device 10 may be used for various endovascular (e.g., neural and peripheral) procedures including procedures for giant cerebral and skull base aneurysms (ruptured and non-ruptured), head and neck arteriovenous fistulas, dissecting intracranial and extracranial vessels, traumatic and non-traumatic vessel injury or rupture (e.g., pelvic hemorrhages in trauma patients, carotid blow-out in patients with head and neck cancers, hemorrhage induced by a neoplasia, etc.), and devascularization prior to (or as an alternative to) surgical resection of various organs or tumors.


In certain embodiments, device 10 may be used for various organs, including for example, the spleen (e.g., endovascular occlusion as a preoperative intervention or as an alternative to surgical resection with indications including traumatic hemorrhage, hypersplenism, bleeding secondary to portal hypertension or splenic vein thrombosis, and various disorders such as thalassemia major, thrombocytopenia, idiopathic thrombocytopenic purpura, Gaucher disease, and Hodgkin disease), the liver (e.g., occlusion of portal veins collaterals as adjunct to a transjugular intrahepatic portosystemic shunt (TIPS), occlusion of the TIPS itself in cases of encephalopathy, occlusion of intrahepatic arterioportal fistulas), the kidney (e.g., endoluminal ureteral occlusion for intractable lower urinary tract fistula with urine leakage, or for the treatment of uretero-arterial fistulae, endovascular occlusion as an alternative to surgical resection for end-stage renal disease or renovascular hypertension requiring unilateral or bilateral nephrectomy and renal transplant with native kidneys in situ), and the heart (e.g., occlusion of coronary arteriovenous fistulas, transarterial embolization of Blalock-Taussig shunts). The application of device 10 is not limited to applications for human patients, but may also include veterinary applications.


In some embodiments, device 10 comprises a tube configured to extend around or through occlusion membrane 40 to be positioned at a target site of the patient. Device 10 also comprises a vacuum source configured to apply a vacuum through the tube for removing at least one of emboli and fluid from the target site. For example, the tube may be placed in a diseased area that has been subjected to occlusion, and the tube may be used to remove body fluids and/or solid components (e.g., blood clots) from the diseased area.



FIG. 5 illustrates an example of expandable member 12 in the process of being loaded on carrier member 16, in accordance with various embodiments of the subject technology. As illustrated, second portion 38 of expandable member 12 is fitted within second notch 36 and secured in place by elongate member 32. As first portion 34 of expandable member 12 is moved toward first notch 30 to be secured in place by elongate member 32, expandable member 12 will extend longitudinally while contracting radially. In addition to longidudinal extension, expandable member 12 may also be rotated about carrier member 16 such that expandable member 12 is compact enough to fit within catheter 44. Once first portion 34 of expandable member 12 is secured in first notch 30, carrier member 16 may be retracted relative to catheter 44. Carrier member 16, along with expandable member 12 may move through catheter 44 when being positioned within luminal structure 14.


In some aspects, “catheter” as used herein may be given at least its ordinary meaning. In some aspects, “catheter” as used herein may refer to any elongate member having a lumen passing therethrough. A catheter, therefore, can be tubular or have other suitable cross sectional shapes, such as at least one of elliptical and polygonal (e.g., triangular, rectangular, hexagonal, octagonal, etc.) cross sectional shapes. Catheter profile can be 4-7 french (or 1.3 to 2.3 mm), or in a range of 0.20″ to 0.40″. The length of catheter 44 can be 130-150 cm.



FIG. 6 illustrates an example of catheter 44 in the process of being positioned within luminal structure 14 at a deployment site, in accordance with various embodiments of the subject technology. Catheter 44 is introduced into the patient (e.g., via femoral artery) and navigated through luminal structure 14 and positioned at the deployment site. In some embodiments, guide wire 46 is inserted into luminal structure 14 and has a soft tip useful for reducing trauma and/or friction. Once guide wire 46 is in place, a guide catheter and/or core 48 is introduced, using guide wire 46 as a guide. Core 48 may be telescopically inserted, acting as an independent component, possessing a tapered soft distal tip (about 4-5 mm long) for better trackability of catheter 44 through the vascular or any other tortuous tubular system. Core 48 may then be used as a guide for the introduction of catheter 44 into luminal structure 14 and for the positioning of catheter 44 at the deployment site. Thus, a portion of catheter 44 is disposed over a portion of core 48, which is disposed over a portion of guide wire 46. After the position of catheter 44 is evaluated and confirmed at the target site (e.g., via flouro imaging), core 48 and guide wire 46 can be removed. Guide wire 46 may be absent when carrier member 16 and expandable member 12 with occlusion membrane 40 are introduced. Thus, occlusion membrane 40 may lack a hole for guide wire 46, allowing for enhanced occlusion. In some embodiments, delivery of expandable member 12 does not require guide wire 46 to run through occlusion membrane 40, thereby obviating the need to poke a hole through occlusion membrane 40 with guide wire 46 for delivery of expandable member 12.



FIG. 7 illustrates an example of a catheter 44 positioned within luminal structure 14 at a deployment site, in accordance with various embodiments of the subject technology. Catheter 44 positioned within luminal structure 14 has an opening therethrough, through which device 10 may be introduced, and through which a portion of device 10 may at least partially emerge from a distal end. In some embodiments, catheter 44 may prevent expandable member 12 from radially expanding such that expandable member 12 is secured between the inner surface of catheter 44 and the outer surface of carrier member 16. In some embodiments, when carrier member 16 is shifted distally relative to catheter 44 until expandable member 12 extends beyond a distal opening of catheter 44 into the deployment site, catheter 44 no longer prevents expandable member 12 from radially expanding. In this regard, expandable member 12 may expand from an undeployed configuration into a partially deployed configuration such that expandable member 12 partially engages an inner surface of the lumen. In some embodiments, expandable member 12 does not automatically expand into a deployed configuration, but is expanded into the deployed configuration via actuation of elongate member 32. In some embodiments, expandable member 12 may be self expandable.



FIG. 8 illustrates an example of device 10 in a position for placement in catheter 44, in accordance with various embodiments of the subject technology. Device 10 comprises carrier member 16, expandable member 12 with first portion 34 secured in first notch 30 via elongate member 32, and second portion 38 secured in second notch 36 via elongate member 32. Device 10 also comprises occlusion membrane 40 coupled to an exterior of expandable member 12. Expandable member 12 is configured to be positioned between carrier member 16 and catheter 44 for stowage of expandable member 12 before expandable member12 is deployed within luminal structure 14. Distal portion 42 of expandable member 12 is loaded into catheter 44 and device 10 is positioned at or near the deployment site by moving carrier member 16 relative to catheter 44.



FIGS. 9 and 10 illustrate an example of device 10 in a position for expansion, engagement, and release, in accordance with various embodiments of the subject technology. Before being released from catheter 44, expandable member 12 is coiled around carrier member 16. As carrier member 16 and expandable member 12 attached thereto are fed through catheter 44, flouro imaging may provide an indication of the position of carrier member 16. Once the desired position is reached, catheter 44 may be pulled back relative to carrier member 16. In some embodiments, expandable member 12 and occlusion membrane 40 may be deployed from catheter 44 by shifting carrier member 16 distally relative to catheter 44 until expandable member 12 and occlusion membrane 40 extend beyond a distal opening of catheter 44 into luminal structure 14. According to various embodiments of the subject technology, expandable member 12 and occlusion membrane 40 may be accurately deployed and/or repositioned at a deployment site. For example, if an operator of device 10 decides that an initial placement of expandable member 12 and occlusion membrane 40 is undesirable, the operator may redeploy and/or reposition the expandable member 12 and occlusion membrane 40 to another deployment site. In some embodiments, carrier member 16 is configured to shift distally relative to catheter 44 until a portion of expandable member 12 extends beyond a distal opening of catheter 44 into a first deployment site for partially deploying expandable member 12 from catheter 44. Carrier member 16 is configured to shift proximally relative to catheter 44 until the portion of expandable member 12 is retracted proximally into catheter 44 for retracting expandable member 12 into catheter 44. In some embodiments, because a proximal portion of carrier member 16 is still secured to expandable member 12, expandable member 12 is also retracted once carrier member 16 is retracted. Catheter 44 is configured to be positioned within the lumen at a second deployment site for deploying expandable member 12 at the second deployment site. Carrier member 16 is configured to shift distally relative to catheter 44 until expandable member 12 extends beyond the distal opening of catheter 44 into the second deployment site for deploying expandable member 12 from catheter 44 into the second deployment site.


In some embodiments, occlusion membrane 40 may be disposed over distal portion 42 of expandable member 12. According to various embodiments of the subject technology, distal portion 42 and occlusion membrane 40 may extend distally beyond a distal opening of catheter 44 such that when catheter 44 is moved within the lumen to a deployment site, the distally extended portion of occlusion membrane 40 is configured to engage a wall of the lumen to reduce friction and potential vessel injury during device tracking and delivery to the deployment site. Thus, the distally extended portion of occlusion membrane 40 may act as a soft tip when catheter 44 is being navigated through the lumen and/or positioned within the lumen. In such a case, an additional tip may not be necessary. In some embodiments, the distally extended portion of occlusion membrane 40 may be extended about 2 mm beyond the distal opening of catheter 44. In some embodiments, the distally extended portion of occlusion membrane 40 may be extended less than about 2 or greater than about 2 mm beyond the distal opening of catheter 44.


In some embodiments, device 10 further comprises one or more stops disposed between catheter 44 and carrier member 16. In some embodiments, a stop is coupled to an inner surface of catheter 44 and is disposed proximal expandable member 12 when expandable member 12 is positioned between carrier member 16 and catheter 44. Another stop is coupled to an outer surface of carrier member 16 and is disposed proximal the first stop. In some embodiments, when carrier member 16 is shifted distally relative to catheter 44 for deploying expandable member 12, the first stop engages the second stop to substantially prevent carrier member 16 from further distal shifting relative to catheter 44.


Once expandable member 12 is positioned and exposed at the deployment site, it may be expanded to engage luminal structure 14. First portion 34 of expandable member 12 may be released from engagement with carrier member 16 by shifting elongate member 32 distally relative to carrier member 16. Such movement moves elongate member 32 out of first notch 30, allowing first portion 34 of expandable member 12 to move from first notch 30, allowing expandable member 12 to expand radially and at least partially engage luminal structure 14.



FIG. 11 illustrates an example of device 10 in an at least partially expanded position ready for release, in accordance with various embodiments of the subject technology. When first portion 34 of expandable member 12 has been released, expandable member 12 and occlusion membrane 40 may remain secured to carrier member 16 until released. At this point, device 10 can be safely removed and pulled back into catheter 44. If full deployment is desired, second portion 38 of expandable member 12 may be released from engagement with carrier member 16 by shifting elongate member 32 distally relative to carrier member 16. Such movement moves elongate member 32 out of second notch 36, allowing second portion 38 of expandable member 12 to move from second notch 36, allowing expandable member 12 to disengage or release from carrier member 16 completely.



FIG. 12 illustrates an example of expandable member 12 and occlusion membrane 40 in place in luminal structure 14, in accordance with various embodiments of the subject technology. Once carrier member 16 is disengaged from expandable member 12, it can me removed from luminal structure 14, leaving expandable member 12 and occlusion membrane 40 in place.



FIG. 13 illustrates an example of carrier member 16 having slots 50, in accordance with various embodiments of the subject technology. Slots 50 may enhance flexibility for better tracking device 10 through tortuous anatomy, while maintaining suitable strength. According to various embodiments of the subject technology, carrier member 16 may have at least two slots 50 formed in carrier member 16 by laser cutting or any other mechanical method.



FIG. 14 illustrates an example of carrier member 16 having tapered cut 52, in accordance with various embodiments of the subject technology. Tapered cut 52 may enhance flexibility for better tracking device 10 through tortuous anatomy, while maintaining suitable strength. Tapered cut 52, as an example may have dimensions from an exemplary full circle of 0.40″ down to 0.20″ at a distal edge. Thus, tapered cut 52 may have a “c” or half-moon shaped cross section. In addition to slots 50 or tapered cut 52, a system of holes drilled in a portion of carrier member 16 may provide flexibility.



FIGS. 15 and 16 illustrate examples of expandable member 12, with occlusion membrane 40 thereon, in accordance with various embodiments of the subject technology.



FIG. 17 illustrates an example of method 1700 for delivering an expandable member to a luminal structure in a patient, in accordance with various embodiments of the subject technology. Method 1700 comprises positioning a carrier member in a luminal structure in a patient (S1702). The carrier member has a cross-sectional area having a first half and a second half that are separated by a line segment intersecting a point along a central long axis of the carrier member. The carrier member has a carrier lumen extending at least partially through the carrier member and intersecting solely the first half of the cross-sectional area. The carrier member has a first notch such that when the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the first notch. An elongate member extends through the carrier lumen across the first notch. An expandable member is carried by the carrier member and includes a first portion that fits within the first notch. The expandable member is configured to expand within and engage the luminal structure such that when the elongate member extends through the carrier lumen and across the first notch, the elongate member secures the first portion to the carrier member. When the first portion is secured to the carrier member, the first portion intersects solely the first half. Method 1700 also comprises moving the elongate member axially through the carrier lumen such that the elongate member permits release of the first portion from the carrier member and expansion of at least part of the expandable member (S1704). According to various embodiments, the moving may comprise retracting the elongate member by an operator who is performing the retracting. According to various embodiments, method 1700 may further comprise moving the carrier member through a catheter when positioning the carrier member within the luminal structure.


The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the present invention has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the invention.


There may be many other ways to implement the invention. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the invention. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the invention, by one having ordinary skill in the art, without departing from the scope of the invention.


It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplary approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.


Terms such as “top,” “bottom,” “front,” “rear” and the like as used in this disclosure should be understood as referring to an arbitrary frame of reference, rather than to the ordinary gravitational frame of reference. Thus, a top surface, a bottom surface, a front surface, and a rear surface may extend upwardly, downwardly, diagonally, or horizontally in a gravitational frame of reference.


A phrase such as an “aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. A phrase such as an aspect may refer to one or more aspects and vice versa. A phrase such as an “embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. A phrase such an embodiment may refer to one or more embodiments and vice versa.


Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.


The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments.


A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” The term “some” refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the invention. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.

Claims
  • 1. A device, for delivering an expandable member to a luminal structure in a patient, comprising: a carrier member, positionable in a luminal structure in a patient, having a a carrier lumen extending along a central axis of the carrier member;a first notch in the carrier member, wherein, when the carrier member is positioned in the luminal structure, the carrier lumen in fluid communication with a body fluid in the luminal structure at the first notch;an elongate member that extends through the carrier lumen and across the first notch; andan expandable member carried by the carrier member and configured to expand within and engage the luminal structure, the expandable member having a first portion that fits within the first notch in an engaged configuration;wherein in the engaged configuration, (i) the first portion passes from a first end of the first notch through a space between the central axis and the elongate member, (ii) the expandable member terminates in the first portion outside of the first notch, beyond a second end of the first notch, and (iii) the elongate member secures the first portion to the carrier member without being positioned between the expandable member and the central axis within a longitudinal extent of the first notch along the central axis.
  • 2. The device of claim 1, wherein the elongate member is configured to be retracted by an operator such that the elongate member permits the release of the first portion.
  • 3. The device of claim 1, wherein the elongate member permits the release of the first portion when the elongate member does not fully extend across the first notch.
  • 4. The device of claim 1, further comprising a second notch in the carrier member; wherein, when the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the second notch;wherein the elongate member extends through the carrier lumen and across the second notch;wherein the expandable member comprises a second portion that fits within the second notch;wherein, (i) the second portion passes from a first end of the second notch through a space between the central axis and the elongate member, (ii) the expandable member terminates in the second portion outside of the first notch, beyond a second end of the second notch, and (iii) the elongate member secures the second portion to the carrier member without being positioned between the expandable member and the central axis within a longitudinal extent of the second notch along the central axis; andwherein the elongate member is configured to move longitudinally through the carrier lumen, after the first portion is released from the carrier member, to release the second portion from the carrier member and release of the expandable member from the carrier member.
  • 5. The device of claim 4, wherein the carrier member has a cross-sectional area comprising a first half and a second half that are separated by a line segment intersecting a point along the central axis of the carrier member, and wherein, when the second portion is secured to the carrier member, the second portion intersects solely the first half.
  • 6. The device of claim 1, wherein the elongate member comprises a wire.
  • 7. The device of claim 1, wherein the expandable member is coiled around the carrier member before being released from the carrier member.
  • 8. The device of claim 1, wherein the carrier member has a cross-sectional area comprising a first half and a second half that are separated by a line segment intersecting a point along the central axis of the carrier member, and wherein the carrier lumen intersects solely the first half.
  • 9. The device of claim 8, wherein, when the first portion is secured to the carrier member, the first portion intersects solely the first half.
  • 10. The device of claim 1, wherein the expandable member is self-expandable such that the first portion is biased in a direction away from the first notch and when the first portion is released by longitudinal movement of the elongate member, the first portion springs out of the first notch.
  • 11. The device of claim 10, wherein the first portion extends from a helical body of the expandable member, the first portion and the helical body being a single, continuous piece of material.
  • 12. The device of claim 11, wherein the first portion comprises a flattened portion of the helical body.
  • 13. The device of claim 1, wherein the first portion is substantially straight.
  • 14. The device of claim 1, wherein the elongate member is configured to move longitudinally through the carrier lumen to release the first portion from the carrier member such that release of the first portion is permitted solely through longitudinal movement of the elongate member.
  • 15. A method, for delivering an expandable member to a luminal structure in a patient, comprising: positioning a carrier member in a luminal structure in a patient, the carrier member having a carrier lumen extending along a central axis of the carrier member, the carrier member having a first notch, wherein, when the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the first notch, wherein an elongate member extends through the carrier lumen across the first notch, wherein an expandable member is carried by the carrier member and includes a first portion that fits within the first notch, wherein the expandable member is configured to expand within and engage the luminal structure, wherein (i) the first portion passes from a first end of the first notch through a space between the central axis and the elongate member, (ii) the expandable member terminates in the first portion outside of the first notch, beyond a second end of the first notch, and (iii) the elongate member secures the first portion to the carrier member without being positioned between the expandable member and the central axis within a longitudinal extent of the first notch along the central axis; andmoving the elongate member longitudinally through the carrier lumen to release the first portion from the carrier member.
  • 16. The method of claim 15, wherein the moving comprises proximally retracting the elongate member.
  • 17. The method of claim 15, wherein the carrier member further comprises a second notch;wherein, when the carrier member is positioned in the luminal structure, the carrier lumen is in fluid communication with a body fluid in the luminal structure at the second notch;wherein the elongate member extends through the carrier lumen across the second notch;wherein the expandable member comprises a second portion that fits within the second notch;wherein, (i) the second portion passes from a first end of the second notch through a space between the central axis and the elongate member, (ii) the expandable member terminates in the second portion outside of the first notch, beyond a second end of the second notch, and (iii) the elongate member secures the second portion to the carrier member without being positioned between the expandable member and the central axis within a longitudinal extent of the second notch along the central axis; andwherein the method further comprises moving, after the first portion is released from the carrier member, the elongate member longitudinally through the carrier lumen to release the second portion from the carrier member and release of the expandable member from the carrier member.
  • 18. The method of claim 17, wherein the moving comprises proximally retracting the elongate member to release the first and second ends from the carrier member.
  • 19. The method of claim 15, wherein the carrier member has a cross-sectional area comprising a first half and a second half that are separated by a line segment intersecting a point along the central axis of the carrier member, and wherein the carrier lumen intersects solely the first half.
  • 20. The method of claim 19, wherein, when the first portion is secured to the carrier member, the first portion intersects solely the first half.
  • 21. The method of claim 15, wherein before the moving, the first portion exerts a radial force against the elongate member in a direction radially away from the first notch, such that the moving permits the first portion to spring out of the first notch.
  • 22. The method of claim 21, wherein the first portion extends from a helical body of the expandable member, the first portion and the helical body being a single, continuous piece of material.
  • 23. The method of claim 22, wherein the first portion comprises a flattened portion of the helical body.
  • 24. The method of claim 15, wherein the first portion is substantially straight.
  • 25. The method of claim 15, wherein the moving comprises moving the elongate member longitudinally through the carrier lumen to release the first portion from the carrier member such that release of the first portion is permitted solely through longitudinal movement of the elongate member.
  • 26. A device, for delivering an expandable member to a luminal structure in a patient, comprising: a carrier member having a lumen extending along a central axis of the carrier member and a notch extending through the carrier member into the lumen;a self-expandable member positioned around the carrier member and terminating in a portion that fits within the notch and extends into and out of the notch; anda wire longitudinally movable through the carrier member lumen and positionable across the notch to secure the portion to the carrier member without being positioned between the expandable member and the central axis within a longitudinal extent of the notch along the central axis.
  • 27. The device of claim 26, wherein the portion is biased in a direction away from the notch such that when the portion is released by longitudinal movement of the wire, the portion springs out of the notch.
  • 28. The device of claim 27, wherein the portion extends from a helical body of the expandable member, the portion and the helical body being a single, continuous piece of material.
  • 29. The device of claim 28, wherein the portion comprises a flattened section of the helical body.
  • 30. The device of claim 26, wherein the lumen comprises first and second halves that are separated by a line segment intersecting a point along a central long axis of the carrier member, wherein the wire extends across the notch within only the first half.
  • 31. The device of claim 26, wherein the carrier member comprises a second notch extending through the carrier member into the lumen, wherein a second portion of the expandable member fits within the second notch to be secured to the carrier member.
  • 32. The device of claim 31, further comprising a second wire longitudinally moveable through the carrier member, wherein the second wire is longitudinally movable across the second notch to secure the second portion to the carrier member.
  • 33. The device of claim 26, wherein the portion is substantially straight.
  • 34. The device of claim 26, wherein release of the portion is permitted solely through longitudinal disengagement of the wire with the portion.
US Referenced Citations (372)
Number Name Date Kind
3805767 Erb Apr 1974 A
3868956 Alfidi et al. Mar 1975 A
3918431 Sinnreich Nov 1975 A
4013063 Bucalo Mar 1977 A
4245623 Erb Jan 1981 A
4553545 Maass et al. Nov 1985 A
4649922 Wiktor Mar 1987 A
4682592 Thorsgard Jul 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4706671 Weinrib Nov 1987 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4768507 Fischell et al. Sep 1988 A
4776337 Palmaz Oct 1988 A
4800882 Gianturco Jan 1989 A
4827946 Kaali et al. May 1989 A
4913141 Hillstead Apr 1990 A
4969890 Sugita et al. Nov 1990 A
5037427 Harada et al. Aug 1991 A
5065751 Wolf Nov 1991 A
5089005 Harada Feb 1992 A
5102417 Palmaz Apr 1992 A
5147370 McNamara et al. Sep 1992 A
5234437 Sepetka Aug 1993 A
5242451 Harada et al. Sep 1993 A
5242452 Inoue Sep 1993 A
5304198 Samson Apr 1994 A
5324306 Makower et al. Jun 1994 A
5334210 Gianturco Aug 1994 A
5342387 Summers Aug 1994 A
5372600 Beyar et al. Dec 1994 A
5417708 Hall et al. May 1995 A
5474089 Waynant Dec 1995 A
5476505 Limon Dec 1995 A
5499995 Teirstein Mar 1996 A
5536274 Neuss Jul 1996 A
5562641 Flomenblit et al. Oct 1996 A
5562698 Parker Oct 1996 A
5607445 Summers Mar 1997 A
5656036 Palmaz Aug 1997 A
5674287 Slepian et al. Oct 1997 A
5693083 Baker et al. Dec 1997 A
5725552 Kotula et al. Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5772668 Summers et al. Jun 1998 A
5782860 Epstein et al. Jul 1998 A
5797952 Klein Aug 1998 A
5797953 Tekulve Aug 1998 A
5830222 Makower Nov 1998 A
5846261 Kotula et al. Dec 1998 A
5868782 Frantzen Feb 1999 A
5902266 Leone et al. May 1999 A
5922009 Epstein et al. Jul 1999 A
5925063 Khosravi Jul 1999 A
5925074 Gingras et al. Jul 1999 A
5928260 Chin et al. Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957929 Brenneman Sep 1999 A
5979446 Loy Nov 1999 A
6010517 Baccaro Jan 2000 A
6019779 Thorud et al. Feb 2000 A
6024765 Wallace et al. Feb 2000 A
6056770 Epstein et al. May 2000 A
6059825 Hobbs et al. May 2000 A
6117157 Tekulve Sep 2000 A
6123715 Amplatz Sep 2000 A
6168622 Mazzocchi Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6210338 Afremov et al. Apr 2001 B1
6214042 Jacobsen et al. Apr 2001 B1
6241678 Afremov et al. Jun 2001 B1
6241758 Cox Jun 2001 B1
6245090 Gilson et al. Jun 2001 B1
6248122 Klumb et al. Jun 2001 B1
6283983 Makower et al. Sep 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6346118 Baker et al. Feb 2002 B1
6361558 Hieshima et al. Mar 2002 B1
6368339 Amplatz Apr 2002 B1
6371953 Beyar et al. Apr 2002 B1
6371979 Beyar et al. Apr 2002 B1
6402760 Fedida Jun 2002 B1
6402772 Amplatz et al. Jun 2002 B1
6432116 Callister et al. Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6447531 Amplatz Sep 2002 B1
6451025 Jervis Sep 2002 B1
6454780 Wallace Sep 2002 B1
6464712 Epstein et al. Oct 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6506204 Mazzocchi Jan 2003 B2
6533805 Jervis Mar 2003 B1
6550480 Feldman et al. Apr 2003 B2
6554849 Jones et al. Apr 2003 B1
6562064 deBeer May 2003 B1
6572643 Gharibadeh Jun 2003 B1
6579303 Amplatz Jun 2003 B2
6585760 Fogarty Jul 2003 B1
6599308 Amplatz Jul 2003 B2
6602271 Adams et al. Aug 2003 B2
6616675 Evard et al. Sep 2003 B1
6623518 Thompson et al. Sep 2003 B2
6629981 Bui et al. Oct 2003 B2
6638243 Kupiecki Oct 2003 B2
6638257 Amplatz Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6645237 Klumb et al. Nov 2003 B2
6656207 Epstein et al. Dec 2003 B2
6660020 Wallace et al. Dec 2003 B2
6660032 Klumb et al. Dec 2003 B2
6663666 Quiachon et al. Dec 2003 B1
6682546 Amplatz Jan 2004 B2
6689148 Sawhney et al. Feb 2004 B2
6702846 Mikus et al. Mar 2004 B2
6719781 Kim Apr 2004 B1
6790218 Jayaraman Sep 2004 B2
6849081 Sepetka et al. Feb 2005 B2
6872211 White et al. Mar 2005 B2
6890341 Dieck et al. May 2005 B2
6899730 Rivelli, Jr. May 2005 B1
6936058 Forde et al. Aug 2005 B2
6974473 Barclay et al. Dec 2005 B2
6984244 Perez et al. Jan 2006 B2
7001409 Amplatz Feb 2006 B2
7011671 Welch Mar 2006 B2
7144408 Keegan et al. Dec 2006 B2
7152605 Khairkhahan et al. Dec 2006 B2
7220270 Sawhney et al. May 2007 B2
7270668 Andreas et al. Sep 2007 B2
7276077 Zadno-Azizi et al. Oct 2007 B2
7294146 Chew et al. Nov 2007 B2
7303571 Makower et al. Dec 2007 B2
7387641 Schmitt Jun 2008 B2
7396362 Jervis Jul 2008 B2
7398780 Callister et al. Jul 2008 B2
7458986 Schmitt Dec 2008 B2
7476232 Deal Jan 2009 B2
7582100 Johnson et al. Sep 2009 B2
7597704 Frazier et al. Oct 2009 B2
7604649 McGuckin, Jr. et al. Oct 2009 B2
7632291 Stephens et al. Dec 2009 B2
7647930 Ginn Jan 2010 B2
7651521 Ton et al. Jan 2010 B2
7666204 Thornton et al. Feb 2010 B2
7682673 Houston et al. Mar 2010 B2
7691124 Balgobin Apr 2010 B2
7699056 Tran et al. Apr 2010 B2
7740616 Smith et al. Jun 2010 B2
7771463 Ton et al. Aug 2010 B2
7785343 Johnson et al. Aug 2010 B2
7785361 Nikolchev et al. Aug 2010 B2
7789860 Brady et al. Sep 2010 B2
7789892 Johnson et al. Sep 2010 B2
7803177 Hartley et al. Sep 2010 B2
7854747 Johnson et al. Dec 2010 B2
7955343 Makower et al. Jun 2011 B2
7967837 Vale Jun 2011 B2
7985250 Kaufmann et al. Jul 2011 B2
7992565 McGuckin, Jr. et al. Aug 2011 B2
8016870 Chew et al. Sep 2011 B2
8016880 Cook et al. Sep 2011 B2
8043357 Hartley Oct 2011 B2
8100958 Fischer et al. Jan 2012 B2
8110267 Houston et al. Feb 2012 B2
8114114 Belson Feb 2012 B2
8118852 Melsheimer Feb 2012 B2
8142456 Rosqueta et al. Mar 2012 B2
8162970 Gilson et al. Apr 2012 B2
8226679 Johnson et al. Jul 2012 B2
8226704 Caro et al. Jul 2012 B2
8308754 Belson Nov 2012 B2
8323305 Epstein et al. Dec 2012 B2
8323350 Nissl Dec 2012 B2
8328840 Gailloud et al. Dec 2012 B2
8333783 Braun et al. Dec 2012 B2
8333796 Tompkins et al. Dec 2012 B2
8343167 Henson Jan 2013 B2
8348994 Leopold et al. Jan 2013 B2
8382771 Gellman et al. Feb 2013 B2
8382821 Richter Feb 2013 B2
8398700 Leopold et al. Mar 2013 B2
8425549 Lenker et al. Apr 2013 B2
8430904 Belson Apr 2013 B2
8663301 Riina et al. Mar 2014 B2
20010000798 Denardo May 2001 A1
20010007946 Lenker et al. Jul 2001 A1
20010031981 Evans et al. Oct 2001 A1
20010037146 Lau et al. Nov 2001 A1
20010044648 Wolinsky et al. Nov 2001 A1
20010046518 Sawhney Nov 2001 A1
20020007206 Bui et al. Jan 2002 A1
20020091439 Baker et al. Jul 2002 A1
20020099437 Anson et al. Jul 2002 A1
20020107565 Greenhalgh Aug 2002 A1
20020123765 Sepetka et al. Sep 2002 A1
20020128707 Kavteladze et al. Sep 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020177855 Greene et al. Nov 2002 A1
20020198588 Armstrong et al. Dec 2002 A1
20030114922 Iwasaka et al. Jun 2003 A1
20030125798 Martin Jul 2003 A1
20030153972 Helmus Aug 2003 A1
20030163146 Epstein et al. Aug 2003 A1
20030171801 Bates Sep 2003 A1
20030187474 Keegan et al. Oct 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030216679 Wolf et al. Nov 2003 A1
20030229366 Reggie et al. Dec 2003 A1
20040010282 Kusleika Jan 2004 A1
20040029994 Cheng et al. Feb 2004 A1
20040055606 Hendricksen et al. Mar 2004 A1
20040073252 Goldberg et al. Apr 2004 A1
20040147869 Wolf et al. Jul 2004 A1
20040153118 Clubb et al. Aug 2004 A1
20040158308 Hogendijk et al. Aug 2004 A1
20040193141 Leopold et al. Sep 2004 A1
20040220663 Rivelli Nov 2004 A1
20040225286 Elliott Nov 2004 A1
20040243219 Fischer et al. Dec 2004 A1
20040249342 Khosravi et al. Dec 2004 A1
20040254517 Quiroz-Mercado et al. Dec 2004 A1
20040260384 Allen Dec 2004 A1
20050027305 Shiu et al. Feb 2005 A1
20050033409 Burke et al. Feb 2005 A1
20050043759 Chanduszko Feb 2005 A1
20050055079 Duran Mar 2005 A1
20050055082 Ben Muvhar et al. Mar 2005 A1
20050113902 Geiser et al. May 2005 A1
20050137681 Shoemaker et al. Jun 2005 A1
20050165442 Thinnes et al. Jul 2005 A1
20050192616 Callister et al. Sep 2005 A1
20050209675 Ton et al. Sep 2005 A1
20050288684 Aronson et al. Dec 2005 A1
20060009798 Callister et al. Jan 2006 A1
20060052822 Mirizzi et al. Mar 2006 A1
20060116714 Sepetka et al. Jun 2006 A1
20060149359 Richter et al. Jul 2006 A1
20060162731 Wondka et al. Jul 2006 A1
20060178727 Richter Aug 2006 A1
20060184089 Makower et al. Aug 2006 A1
20060200191 Zadno-Azizi Sep 2006 A1
20060241675 Johnson et al. Oct 2006 A1
20060241690 Amplatz et al. Oct 2006 A1
20070038178 Kusleika Feb 2007 A1
20070043419 Nikolchev et al. Feb 2007 A1
20070060946 Keegan et al. Mar 2007 A1
20070088388 Opolski et al. Apr 2007 A1
20070112381 Figulla et al. May 2007 A1
20070118209 Strecker May 2007 A1
20070129753 Quinn et al. Jun 2007 A1
20070135826 Zaver et al. Jun 2007 A1
20070150045 Ferrera Jun 2007 A1
20070156224 Cioanta et al. Jul 2007 A1
20070163601 Pollock et al. Jul 2007 A1
20070168018 Amplatz et al. Jul 2007 A1
20070168019 Amplatz et al. Jul 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070221230 Thompson et al. Sep 2007 A1
20070239191 Ramzipoor Oct 2007 A1
20070247680 Nakane et al. Oct 2007 A1
20070265656 Amplatz et al. Nov 2007 A1
20070265658 Nelson et al. Nov 2007 A1
20080017201 Sawhney Jan 2008 A1
20080045996 Makower et al. Feb 2008 A1
20080086214 Hardin et al. Apr 2008 A1
20080103522 Steingisser et al. May 2008 A1
20080132906 Rasmussen Jun 2008 A1
20080178890 Townsend et al. Jul 2008 A1
20080200945 Amplatz et al. Aug 2008 A1
20080215087 Pavcnik et al. Sep 2008 A1
20080221600 Dieck et al. Sep 2008 A1
20080269719 Balgobin Oct 2008 A1
20080302368 McGuckin, Jr. et al. Dec 2008 A1
20090005847 Adams Jan 2009 A1
20090018562 Amplatz et al. Jan 2009 A1
20090018636 Gailloud et al. Jan 2009 A1
20090025820 Adams Jan 2009 A1
20090030497 Metcalf et al. Jan 2009 A1
20090043330 To Feb 2009 A1
20090062841 Amplatz et al. Mar 2009 A1
20090078270 Meier et al. Mar 2009 A1
20090082803 Adams et al. Mar 2009 A1
20090099647 Glimsdale et al. Apr 2009 A1
20090112251 Qian et al. Apr 2009 A1
20090131959 Rolland May 2009 A1
20090132020 Watson May 2009 A1
20090138078 Paul, Jr. et al. May 2009 A1
20090157053 Davis et al. Jun 2009 A1
20090171386 Amplatz et al. Jul 2009 A1
20090178682 Tal et al. Jul 2009 A1
20090187214 Amplatz et al. Jul 2009 A1
20090209855 Drilling et al. Aug 2009 A1
20090210047 Amplatz et al. Aug 2009 A1
20090210048 Amplatz et al. Aug 2009 A1
20090216185 Gregorich et al. Aug 2009 A1
20090240326 Wilson et al. Sep 2009 A1
20090276029 Caro et al. Nov 2009 A1
20090276039 Meretei Nov 2009 A1
20090277455 Lee-Sepsick et al. Nov 2009 A1
20090281610 Parker Nov 2009 A1
20100006105 Carter et al. Jan 2010 A1
20100030321 Mach Feb 2010 A1
20100049307 Ren Feb 2010 A1
20100057194 Ryan Mar 2010 A1
20100063578 Ren et al. Mar 2010 A1
20100063582 Rudakov Mar 2010 A1
20100089406 Kachiguina Apr 2010 A1
20100106235 Kariniemi et al. Apr 2010 A1
20100114307 Agnew et al. May 2010 A1
20100121370 Kariniemi May 2010 A1
20100174269 Tompkins et al. Jul 2010 A1
20100223046 Bucchieri et al. Sep 2010 A1
20100223048 Lauder Sep 2010 A1
20100249691 Van Der Mooren et al. Sep 2010 A1
20100268201 Tieu et al. Oct 2010 A1
20100268260 Riina et al. Oct 2010 A1
20100294282 Chu et al. Nov 2010 A1
20100312268 Belson Dec 2010 A1
20100318178 Rapaport et al. Dec 2010 A1
20100324585 Miles et al. Dec 2010 A1
20100324586 Miles et al. Dec 2010 A1
20100324587 Miles et al. Dec 2010 A1
20100324588 Miles et al. Dec 2010 A1
20110029067 McGuckin, Jr. et al. Feb 2011 A1
20110040371 Hanssen et al. Feb 2011 A1
20110124958 Nelson May 2011 A1
20110125132 Krolik et al. May 2011 A1
20110202087 Vale Aug 2011 A1
20110202129 Fofsell Aug 2011 A1
20110218479 Rottenberg et al. Sep 2011 A1
20110264132 Strauss et al. Oct 2011 A1
20110264195 Griswold Oct 2011 A1
20110282343 Kunis Nov 2011 A1
20110301630 Hendriksen et al. Dec 2011 A1
20110313506 Ray et al. Dec 2011 A1
20110319906 Rudakov et al. Dec 2011 A1
20120010556 Faul et al. Jan 2012 A1
20120022572 Braun et al. Jan 2012 A1
20120083822 Anukhin et al. Apr 2012 A1
20120089216 Rapaport et al. Apr 2012 A1
20120101510 Lenker et al. Apr 2012 A1
20120116350 Strauss et al. May 2012 A1
20120123511 Brown May 2012 A1
20120123514 Kunis May 2012 A1
20120143301 Maslanka et al. Jun 2012 A1
20120172911 Welch Jul 2012 A1
20120192872 Rudakov et al. Aug 2012 A1
20120209310 Chen et al. Aug 2012 A1
20120239077 Zaver et al. Sep 2012 A1
20120245620 Gilson et al. Sep 2012 A1
20120245668 Kariniemi et al. Sep 2012 A1
20120259354 Kellett Oct 2012 A1
20120277842 Kunis Nov 2012 A1
20120289988 Riina et al. Nov 2012 A1
20120289994 Larson et al. Nov 2012 A1
20120316584 Miles et al. Dec 2012 A1
20120330347 Becking et al. Dec 2012 A1
20120330348 Strauss et al. Dec 2012 A1
20130053879 Gailloud et al. Feb 2013 A1
20130102996 Strauss Apr 2013 A1
20130103074 Riina et al. Apr 2013 A1
20130109987 Kunis et al. May 2013 A1
20130116774 Strauss et al. May 2013 A1
20130123899 Leopold et al. May 2013 A1
20130178889 Miles et al. Jul 2013 A1
20130204282 Nelson Aug 2013 A1
20130204311 Kunis Aug 2013 A1
20130289714 Strauss et al. Oct 2013 A1
20140128780 Kennedy et al. May 2014 A1
20140215792 Leopold et al. Aug 2014 A1
20140222059 Leopold et al. Aug 2014 A1
Foreign Referenced Citations (115)
Number Date Country
2527227 Dec 2002 CN
1166721 Jan 2002 EP
1188413 Mar 2002 EP
1317908 Jun 2003 EP
1600110 Nov 2005 EP
1707233 Oct 2006 EP
1752112 Feb 2007 EP
1813196 Aug 2007 EP
1820436 Aug 2007 EP
1852073 Nov 2007 EP
2248471 Nov 2010 EP
2366362 Sep 2011 EP
2366363 Sep 2011 EP
2366364 Sep 2011 EP
2404580 Jan 2012 EP
2583636 Apr 2013 EP
2404860 Feb 2005 GB
2494820 Mar 2013 GB
H 07-000405 Jan 1995 JP
07-18501 Jul 1995 JP
2006-181015 Jul 2006 JP
2010-532180 Oct 2010 JP
2012-525859 Oct 2012 JP
WO-8300997 Mar 1983 WO
WO-9214408 Sep 1992 WO
WO-9400179 Jan 1994 WO
WO-9524158 Sep 1995 WO
WO-9525480 Sep 1995 WO
WO-9532018 Nov 1995 WO
WO-9618361 Jun 1996 WO
WO-9713463 Apr 1997 WO
WO-9713471 Apr 1997 WO
WO-9727893 Aug 1997 WO
WO-9727897 Aug 1997 WO
WO-9727898 Aug 1997 WO
WO-9731672 Sep 1997 WO
WO-9808456 Mar 1998 WO
WO-9831308 Jul 1998 WO
WO-9834546 Aug 1998 WO
WO-9846115 Oct 1998 WO
WO-9846119 Oct 1998 WO
WO-9912484 Mar 1999 WO
WO-9923976 May 1999 WO
WO-9925273 May 1999 WO
WO-9944542 Sep 1999 WO
WO-9948545 Sep 1999 WO
WO-9949793 Oct 1999 WO
WO-9949910 Oct 1999 WO
WO-9962430 Dec 1999 WO
WO-0009195 Feb 2000 WO
WO-0016847 Mar 2000 WO
WO-0027303 May 2000 WO
WO-0067671 Nov 2000 WO
WO-0132254 May 2001 WO
WO-0164112 Sep 2001 WO
WO-0180776 Nov 2001 WO
WO-0180777 Nov 2001 WO
WO-0189413 Nov 2001 WO
WO-0203889 Jan 2002 WO
WO-03001970 Jan 2003 WO
WO-03073961 Sep 2003 WO
WO-03073962 Sep 2003 WO
WO-03101518 Dec 2003 WO
WO-2004006804 Jan 2004 WO
WO-2004073557 Sep 2004 WO
WO-2005020786 Mar 2005 WO
WO-2005092241 Oct 2005 WO
WO 2005117755 Dec 2005 WO
WO-2006017470 Feb 2006 WO
WO-2006028943 Mar 2006 WO
WO-2006031602 Mar 2006 WO
WO-2006034153 Mar 2006 WO
WO-2006074163 Jul 2006 WO
WO-2006096342 Sep 2006 WO
WO-2006111801 Oct 2006 WO
WO-2006134354 Dec 2006 WO
WO-2007061927 May 2007 WO
WO-2007070544 Jun 2007 WO
WO-2007085373 Aug 2007 WO
WO-2007127351 Nov 2007 WO
WO-2007149844 Dec 2007 WO
WO-2008010197 Jan 2008 WO
WO-2008100790 Aug 2008 WO
WO-2008112501 Sep 2008 WO
WO-2008153653 Dec 2008 WO
WO-2009064618 May 2009 WO
WO-2009077845 Jun 2009 WO
WO-2009088905 Jul 2009 WO
WO-2009124288 Oct 2009 WO
WO-2009126747 Oct 2009 WO
WO-2010009019 Jan 2010 WO
WO-2010047644 Apr 2010 WO
WO-2010075565 Jul 2010 WO
WO-2010085344 Jul 2010 WO
WO-2010096717 Aug 2010 WO
WO-2010130617 Nov 2010 WO
WO-2010135352 Nov 2010 WO
WO-2010146581 Dec 2010 WO
WO-2010148246 Dec 2010 WO
WO-2011011581 Jan 2011 WO
WO-2011153304 Dec 2011 WO
WO-2011163157 Dec 2011 WO
WO-2012002944 Jan 2012 WO
WO-2012040380 Mar 2012 WO
WO-2012067724 May 2012 WO
WO-2012109367 Aug 2012 WO
WO-2012111137 Aug 2012 WO
WO-2012120490 Sep 2012 WO
WO-2012131672 Oct 2012 WO
WO-2012134761 Oct 2012 WO
WO-2012135859 Oct 2012 WO
WO-2012166804 Dec 2012 WO
WO-2013055703 Apr 2013 WO
WO-2013059511 Apr 2013 WO
WO-2013067299 May 2013 WO
Non-Patent Literature Citations (28)
Entry
Aydogan, Transcatheter Embolization Treatment of Coronary Arteriovenous Fistulas, Asian Cardiovascular & Thoracic Annals, 2003, pp. 63-67, vol. 11, No. 1.
Berguer et al., Cure by Combination of Operation and Detachable Intravascular Balloon, Ann. Surg. Jul. 1982, pp. 65-68, vol. 196, No. 1.
Cheng et al., Minimally Invasive Keyhole Approach for Removal of a Migratory Balloon Complicated by Endovascular Embolization of a Carotid-Cavernous Fistula, Minim. Invasive Neurosurgl, 2006, pp. 305-308, vol. 49.
DeSouza et al., Embolization with Detachable Balloons—Applications Outside the Head, Clinical Radiology, Apr. 21, 1992, pp. 170-175, vol. 46.
Ferro et al, Percutaneous Transcatheter Embolization of a Large Pulmonary Arteriovenous Fistula with an Amplatzer Vascular Plug, Cardovacs Intervent Radiol, 2007, pp. 328-331, vol. 30.
Hawkins et al., The Permeability of Detachable Latex Rubber Balloons—An In Vitro Study, Investigative Radiology, Dec. 1987, pp. 969-972, vol. 22.
Hirai et al., Emergency Balloon Embolization for Carotid Artery Rupture Secondary to Postoperative Infection, Cardiovasc Intervent Radiol, 1996, pp. 50-52, vol. 19.
Kadir et al., Therapeutic Embolization of the Kidney with Detachable Silicone Balloons, The Journal of Urology, Jan. 1983, pp. 11-13, vol. 129.
Kallmes et al., The Use of Hydrocoil for Parent Artery Occlusion, AJNR Am J Neuroradiol, Sep. 2004, pp. 1409-1410, vol. 25.
Kaufman, et al., Detachable Balloon-Modified Reducing Stent to Treat Hepatic Insufficiency After Transjugular Intrahepatic Portosystemic Shunt Creation, J Vasc Interv Radiol., May 2003, pp. 635-638, vol. 14, No. 5.
Luo, Chao-Bao et al., Endovascular Treatment of the Carotid Artery Rupture with Massive Hemorrhage, J. Chin Med Assoc., Mar. 2003.
Makita, et al., Guide-Wire-directed Detachable Balloon: Clinical Application in Treatment of Varicoceles, Radiology, 1992, pp. 575-577, vol. 183.
Marshall et al., Treatment of Traumatic Renal Arteriovenous Fistulas by Detachable Silicone Balloon Embolization, The Journal of Urology, Aug. 1979, pp. 237-239, vol. 122.
Perala et al., Comparison of Early Deflation Rate of Detachable Latex and Silicone Balloons and Observations on Persistent Varicocele, J. Vasc. Interv. Radiol. Sep.-Oct. 1998, pp. 761-765, vol. 9, No. 5.
Pollak et al., Clinical Results of Transvenous Systemic Embolotherapy with a Neuroradiologic Detachable Balloon, Radiology, May 1994, pp. 477-482, vol. 191, No. 2.
Reidy et al., Transcatherer Occlusion of Coronary to Bronchial Anastomosis by Detachable Balloon Combined with Coronary Angioplasty at Same Procedure, Brit Heart J. 1983, pp. 284-287, vol. 49.
Reidy et al., Transcatheter Occlusion of a Blalock-Taussig Shunt with a Detachable Balloon in a Child, Bri Heart Journal, 1983, pp. 101-103, vol. 50.
Ross et al., The Vascular Plug: A New Device for Parent Artery Occlusion, AJNR Am J Neuroradiol, Feb. 2007, pp. 385-386, vol. 28.
Serbinenko, F.A., Balloon Catheterization and Occlusion of Major Cerebral Vessels, J. Neurosurg. Aug. 1974, pp. 125-145, vol. 41.
Tasar, et al., Intrahepatic Arterioportal Fistula and its Treatment with Detachable Balloon and Transcatheter Embolization with Coils and Microspheres, Journal of Clinical Imaging, 2005, pp. 325-330, vol. 29.
Wehman, et al., Giant Cerebral Aneurysms: Endovascular Challenges, Neurosurgery, Nov. 2006, pp. S125-S138, vol. 59, No. 5.
White, et al., Occlusion of Varicoceles with Detachable Balloons, Radiology, May 1981, pp. 327-334, vol. 139.
Serbinenko, F.A., Occlusion by Balooning of Sacular Aneurysms of the Cerebral Arteries, Vopr, Neirokhir, Jul.-Aug. 1974, pp. 8-15, vol. 4.
Serebinko, F.A., Balloon Occlusion of Cavernous Portion of the Carotid Artery as a Method of Treating Carotid Cavity Anastomoses, Vopr. Neirokhir, Nov.-Dec. 1971, pp. 3-9, vol. 6.
U.S. Appl. No. 13/828,974, filed Mar. 14, 2013.
U.S. Appl. No. 14/044,794, filed Oct. 2, 2013.
U.S. Appl. No. 14/101,171, filed Dec. 9, 2013.
U.S. Appl. No. 14/281,797, filed May 19, 2014.
Related Publications (1)
Number Date Country
20120095489 A1 Apr 2012 US